Conciseness

Mostly efficient — the bulk is genuinely tool-specific knowledge (parameter gotchas like 'name (NOT query)', association-type semantics, GenCC tiers, review-star confidence levels) — but it includes unnecessary explanation of concepts Claude already knows: the four inheritance-mode definitions ('Autosomal dominant: look for heterozygous variants in ONE copy...'), the basic consequence hierarchy, and a long padded parenthetical on deep intronic variants. This is more than the 'minor instances' of the level-4 anchor, so level 3 fits best.

Actionability

Concrete, executable guidance throughout: exact parameter names, defaults, and aliases for ~25 tools, explicit gotchas, and two example workflows with real call signatures like Orphanet_search_diseases(name="Marfan syndrome"). It falls short of the copy-paste-ready level 5 because the workflows are tool-call sketches, not runnable Python — the 'COMPUTE, DON'T DESCRIBE' section instructs running Python via Bash but never shows how to invoke a ToolUniverse tool from code.

Workflow Clarity

The 10 phases (0-9) are clearly sequenced with an explicit ordering rationale ('phenotype -> disease -> gene -> variant, not the reverse'), fallback strategies provide error-recovery loops when tools return nothing, and the Completeness Checklist and evidence-grading tiers act as end-of-workflow validation. No destructive or batch operations apply a cap. This matches the level-5 anchor; level 4 would lack the checklist or fallback loops.

Progressive Disclosure

Structure is present and well-organized (phase headers, examples, mistakes, limitations), but this is a 283-line monolithic SKILL.md with no bundle files — the per-tool API reference (parameters, defaults, aliases for ~25 tools) is inlined in the body when it clearly belongs in references/ files, matching the level-3 anchor 'content that should be separate is inline' rather than level 4's 'most content is appropriately placed'.

Specificity

The description lists multiple specific concrete actions with named resources — 'disease identification (Orphanet), causative gene discovery, gene-disease validity (GenCC), variant interpretation (ClinVar), and translational research (ClinicalTrials.gov, drug repurposing for orphans)' — covering the full workflow comprehensively, which matches the level-5 anchor rather than the minor-gaps level 4.

Completeness

Both 'what' and 'when' are explicitly answered: the what is a detailed multi-capability list, and the when is the explicit clause 'Use for rare-disease-gene curation, novel-gene-discovery analysis, and rare-disease drug-development support', matching the level-5 anchor exactly; level 4 would require the when to be less explicit.

Trigger Term Quality

Good natural keyword coverage ('rare disease', 'rare-disease-gene curation', 'novel-gene-discovery analysis', 'rare-disease drug-development support'), but common user phrasings and synonyms like 'orphan disease', 'HPO', or 'what genes cause' are absent from the description text itself (they only exist in the separate triggers block), so it falls short of the comprehensive-synonym level-5 anchor.

Distinctiveness Conflict Risk

It carves out a clear niche (rare-disease genomics with distinct named resources Orphanet/GenCC/ClinVar) with minimal overlap risk against generic genomics or disease-research skills, matching the level-5 'clear niche with distinct triggers' anchor.